Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL
联合抑制受体酪氨酸和 p21 活化激酶作为儿童 ALL 的治疗策略
期刊:Blood Advances
影响因子:7.4
doi:10.1182/bloodadvances.2018020693
Ina-Katrin Siekmann, Kevin Dierck, Sebastian Prall, Marianne Klokow, Julia Strauss, Sophia Buhs, Antonina Wrzeszcz, Michael Bockmayr, Florian Beck, Magdalena Trochimiuk, Kristina Gottschling, Victoria Martens, Melissa Khosh-Naucke, Helwe Gerull, Jürgen Müller, Lena Behrmann, Martin Blohm, René P Zah